NAP
AMGN icon

New Amsterdam Partners’s Amgen AMGN Stock Holding History

New Amsterdam Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,549
Closed -$373K – 120
2016
Q4 		$373K Sell
2,549
-21
-0.8% -$3.16K 0.08% 114
2016
Q3 		$429K Sell
2,570
-113
-4% -$19.1K 0.1% 106
2016
Q2 		$408K Buy
+2,683
New +$417K 0.1% 106

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New Amsterdam Partners's AMGN Position: Q1 2017 in Review

New Amsterdam Partners sold out of Amgen (AMGN) in Q1 2017, closing a stake of 2,549 shares — an estimated $373K sold.

New Amsterdam Partners first reported a position in AMGN in Q2 2016 and held it in 3 quarters. The position peaked at $429K in Q3 2016. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • New Amsterdam Partners reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • New Amsterdam Partners sold 2,549 Amgen shares in Q1 2017, an estimated $373K.
  • New Amsterdam Partners first reported a position in Amgen in Q2 2016 and held it in 3 quarters.
  • New Amsterdam Partners's Amgen position peaked at $429K in Q3 2016.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on New Amsterdam Partners's 13F filing for Q1 2017, filed 3 May 2017.